Results 11 to 20 of about 8,431 (215)

Differentiating Branch Duct and Mixed IPMN in Endoscopically Collected Pancreatic Cyst Fluid via Cytokine Analysis [PDF]

Gastroenterology Research and Practice, 2012
Background. Differentiating branch duct from mixed intraductal papillary mucinous neoplasm (BD-IPMN) is problematic, but clinically important as mixed IPMNs are managed surgically, while some BD-IPMN may be followed. Inflammatory mediator proteins (IMPs)
Linda S. Lee, Andrew M. Bellizzi, Peter A. Banks, Nisha I. Sainani, Vivek Kadiyala, Shadeah Suleiman, Darwin L. Conwell, Joao A. Paulo   +7 more
doaj   +2 more sources

Pancreatico-gastric fistula arising from IPMN associated with ductal adenocarcinoma of the pancreas: a case report and a literature review [PDF]

Frontiers in Surgery, 2023
IntroductionAn intraductal papillary mucinous neoplasm (IPMN) is a potentially malignant cystic tumor that is characterized by an excessive papillary proliferation of mucin-producing epithelial cells.
M. AbuDalu, Y. Munz, G. Ohana
doaj   +2 more sources

EZH2 is associated with malignant behavior in pancreatic IPMN via p27Kip1 downregulation. [PDF]

PLoS ONE, 2014
The epigenetic mechanism of tumorigenesis in pancreatic intraductal papillary mucinous neoplasm (IPMN) remains largely unknown. The aim of this study is to examine the role of enhancer of zeste homologue 2 (EZH2) alteration in pancreatic IPMN progression.
Hideyuki Kuroki, Hiromitsu Hayashi, Hirohisa Okabe, Daisuke Hashimoto, Hiroshi Takamori, Osamu Nakahara, Shigeki Nakagawa, Yukiko Fukushima, Akira Chikamoto, Toru Beppu, Masahiko Hirota, Ken-ichi Iyama, Hideo Baba   +12 more
doaj   +2 more sources

Branch Duct IPMN-Associated Acute Pancreatitis in a Large Single-Center Cohort Study

Diagnostics
Background/Objectives: IPMNs are a possible cause of acute pancreatitis (AP). IPMN-associated-AP is considered a relative indication for surgery for the prevention of recurrent attacks of pancreatitis and for a hypothesized increased cancer risk.
Nicolò de Pretis, Luigi Martinelli, Antonio Amodio, Federico Caldart, Salvatore Crucillà, Maria Sole Battan, Alberto Zorzi, Stefano Francesco Crinò, Maria Cristina Conti Bellocchi, Laura Bernardoni, Giulia De Marchi, Pietro Campagnola, Roberto Salvia, Armando Gabbrielli, Alessandro Marcon, Luca Frulloni   +15 more
doaj   +2 more sources

Intraductal Papillary Mucinous Neoplasms (IPMN): Diagnosis, Classification, and Risk Assessment - A Review of Current Medical Knowledge [PDF]

Journal of Education, Health and Sport
Introduction In recent years, the widespread utilisation of advanced imaging modalities has led to a surge in the detection rate of pancreatic cystic lesions, particularly intraductal papillary mucinous neoplasms (IPMN).
Karina Otręba, Joanna Cieszkowska, Karolina Czupryńska, Piotr Daniel, Michał Leśkiewicz, Justyna Składanek   +5 more
doaj   +2 more sources

Intrabiliary Acetylcysteine Infusion for Biliary Obstruction in a Case of Chronic Pancreatitis with Pancreatic Head IPMN

Journal of Digestive Endoscopy, 2020
Successful biliary drainage in case of intraductal papillary mucinous neoplasm (IPMN) with thick mucus by ERCP and internal drainage alone is usually inadequate.
Paul K. Vincent, Hasim Ahamed, Rajesh Gopalakrishna, Ramachandran Menon, Rama P. Venu   +4 more
doaj   +1 more source

Intraductal papillary mucinous neoplasms of the pancreas: Uncommon imaging presentation, evolution and comparison of guidelines

European Journal of Radiology Open, 2023
Pancreatic cystic lesions are often asymptomatic, incidentally detected and include a range of entities with varying degrees of concern for malignancy.
Chiara Minelli, Federico Balducci, Cristina Cavalleri, Anna Caterina Milanetto, Francesco Ferrara, Filippo Crimì, Emilio Quaia, Federica Vernuccio   +7 more
doaj   +1 more source

Anatomical pancreatic variants in intraductal papillary mucinous neoplasm patients: a cross-sectional study

BMC Gastroenterology, 2022
Background No previous studies have examined the possible relationship between intraductal papillary mucinous neoplasm (IPMN) and the developmental ductal variations of the pancreas, such as an ansa pancreatica and a meandering main pancreatic duct (MMPD)
Katarina Johansson, Harri Mustonen, Hanna Seppänen, Tiina E. Lehtimäki   +3 more
doaj   +1 more source

The molecular, immune features, and risk score construction of intraductal papillary mucinous neoplasm patients

Frontiers in Molecular Biosciences, 2022
Intraductal papillary mucinous neoplasm (IPMN) is a common pancreatic precancerous lesion, with increasing incidence in recent years. However, the mechanisms of IPMN progression into invasive cancer remain unclear.
Xing Huang, Yipeng Feng, Yipeng Feng, Yipeng Feng, Dawei Ma, Hanlin Ding, Hanlin Ding, Hanlin Ding, Gaochao Dong, Gaochao Dong, Yan Chen, Xiaochen Huang, Jingyuan Zhang, Xinyu Xu, Chen Chen   +14 more
doaj   +1 more source

Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucinous neoplasms

Clinical Epigenetics, 2023
Background Intraductal papillary mucinous neoplasms (IPMNs), a type of cystic pancreatic cancer (PC) precursors, are increasingly identified on cross-sectional imaging and present a significant diagnostic challenge.
Ankit Chhoda, Anup Sharma, Bethsebie Sailo, Haoyu Tang, Nensi Ruzgar, Wan Ying Tan, Lee Ying, Rishabh Khatri, Anand Narayanan, Shrikant Mane, Bony De Kumar, Laura D. Wood, Christine Iacobuzio-Donahue, Christopher L. Wolfgang, John W. Kunstman, Ronald R. Salem, James J. Farrell, Nita Ahuja   +17 more
doaj   +1 more source